Zoster;Zoster

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 5, 1997, Pages 132-139

  Gross, G ^a,b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; PENCICLOVIR; SORIVUDINE; VALACICLOVIR; VIDARABINE;

DRUG STRUCTURE; HERPES ZOSTER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; REVIEW; SKIN INFECTION; IMMUNE DEFICIENCY; IMMUNOLOGY; VIRAL SKIN DISEASE;

ANTIVIRAL AGENTS; HERPES ZOSTER; HUMANS; IMMUNOCOMPROMISED HOST; SKIN DISEASES, VIRAL;

EID: 0031592414     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1047587     Document Type: Review

References (50)

1. Balfour, H. H. jr.: Varicella zoster virus infections in immunocompromised hosts. Amer. J. Med. 85 (1988), 68-73.
2. Barr, R. J., J. Hertens, J. H. Graham: Rapid method for Tzanck preparation. J. Amer. Med. Ass. 237 (1977), 1119-1120.
3. Barret, A. P., C. H. Katelaris, J. G. L. Morris, M. Schiffer: Zoster sine herpete of the trigeminal nerve. Oral Surg. 75 (1993), 173-175.
4. Beutner, K. R., D. J. Friedman, C. Forszpaniak, P. L. Andersen, M. J. Wood: Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob. Agents Chemother. 39 (1995), 1546-1553.
5. Caumes E., C. Katlama, S. I. Bourneria et al.: Zona sacre compliqué d' une rétention vesicale aigue. Presse méd. 19 (1990), 1950.
6. Clemmensen, O. J., K. E. Andersen: ACTH versus prednisone and placebo in herpes zoster treatment. Clin. exp. Dermatol. 9 (1984), 557-563.
7. Cohen, R. R., V. P. Beltraini, M. E. Grossman: Disseminated herpes zoster in patients with human immunodeficiency virus infection. Amer. J. Med. 84 (1988), 1076-1080.
8. Colebunders R., J. M. Mann, H. Francis et al.: Herpes zoster in African patients. J. inf. Dis. 157 (1988), 314-318.
9. Disler, R. S., J. S. Dover: Chronic localized herpes zoster in the acquired immunodeficiency syndrome. Arch. Dermatol. 126 (1990), 1105-1106.
10. Folkers, E., J. Vreeswijk, A. P. Oranje: Rapid diagnosis of varicella and herpes zoster. Brit. J. Dermatol. 121 (1989), 287-296.
11. Friedman-Kien, A. E., F. L. Lafleur, E. Gendler et al.: Herpes zoster: a possible early sign for development of acquired immunodeficiency syndrome in high-risk individuals. J. Amer. Acad. Dermatol. 14 (1986), 1023-1028.
12. Galagher, J. G., T. C. Merigan: Prolonged herpes zoster infection associated with immunosuppressive therapy. Am. Intern. Med. 91 (1979), 842-846.
13. Glynn, C., G. Crockford, D. Garaghan, P. Gardno, D. Price, J. Miller: Epidemiology of shingles. J. roy. Soc. Med. 83 (1990), 617-619.
14. Gottschau, P., W. Trojaborg: Abdominal muscle paralysis associated with herpes zoster. Acta neurol. Scand. 84 (1991), 344-347.
15. de Greef, H.: Famciclovir, a new oral antiherpes drug. Int. J. antimicrob. Agents 4 (1995), 241-246.
16. Gross, G., J. Schumann: Herpesvirus-Infektionen. Indikationen zur Chemotherapie in der Dermatovenerologie. Hautarzt 41 (1990), 591-601.
17. Guess, H. A., D. D. Broughton, L. J. Melton III, L. T. Kurland: Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics 76 (1985), 512-517.
18. Hope-Simpson, R. E.: The nature of herpes zoster. A long term study and new hypothesis. Proc. roy. Soc. Med. 58 (1965), 9-20.
19. Hope-Simpson, R. E.: Postherpetic neuralgia. J. roy. Coll. gen. Practit. 25 (1975), 571-575.
20. Hoppenjans, W. B., M. R. Bibler, R. L. Orne et al.: Prolonged cutaneous herpes zoster in acquired immunodeficiency syndrome. Arch. Dermatol. 126 (1990), 1048-1050.
21. Joseph, T. P., R. P. Chand, S.U. Tariq et al.: Acute proximal myopathy due to herpes zoster. J. roy. Soc. Med. 86 (1993), 360.
22. Kalman, C. M., O. L. Laskin: Herpes zoster and zosteriform herpes simplex virus infections in immunocompetent adults. Amer. J. Med. 81 (1986), 775-778.
23. Kost, R. G., S. E. Straus: Postherpetic neuralgia - pathogenesis, treatment and prevention. New Engl. J. Med. 335 (1996), 23-42.
24. Levin, M. J., M. Murray, G. O. Zerbe, C. J. White, A. R. Hayward: Immune response of elderly persons 4 years after receiving a live attenuated varicella vaccine. J. infect. Dis. 170 (1994), 522-526.
25. Liesegang, T. J.: Diagnosis and therapy of herpes zoster ophthalmicus. Ophthalmology 98 (1991), 1216-1229.
26. Malin, J. P.: Zoster und Nervensystem. Dtsch. med. Wschr. 121 (1996), 635-638.
27. Marsh, R. J., M. Cooper: Double-masked trial of topical acyclovir and steroides in the treatment of herpes zoster ocular inflammation. Brit. J. Ophthalmol. 75 (1991), 542-546.
28. Meier J. L., S. E. Strauss: Comparative biology of latent varicella-zoster virus and herpes simplex virus infections. J. Inf. Dis. 166 (Suppl.)(1992), S 13-S 23.
29. Meister, W., A. Neis, G. Gross, H. W. Doerr, W. Höbel, J.-P. Malin, B.-J. Reimann, J. von Essen, C. Wittke, P. Wutzler: Prognostic factors of postherpetic neuralgia in ambulatory patients (in preparation).
30. Melbye, M., R. J. Grossman, J. J. Goebert, M. E. Eysler, R. J. Bizzar: Risk of AIDS after herpes zoster. Lancet 1 (1978), 728-730.
31. de Moragas, J. M., R. R. Kierland: The outcome of patients with herpes zoster. Arch. Dermatol. 75 (1957), 193-195.
32. Nikkels, A. F., S. Debrus, C. Sadzot-Delvaux et al.: Comparative immunohistochemical study of herpes simplex and varicella-zoster infections. Virchows Archiv A. 422 (1993), 121-126.
33. Osborne, T. A., R. B. Thomson, C. C. Bostick et al.: Several methods of detecting varicella zoster virus (VZV) and measuring VZV immune status. Diagn. microbiol. infect. Dis. 12 (1986), 287-288.
34. Oxman, M. N.: Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 45 (Suppl. 8) (1995), 41-46.
35. Ragozzino, M. W., L. J. Melton, T. L. Kurland, C. P. Chu, N. O. Perry: Population based study of herpes zoster and its sequelae. Medicine (Baltimore) 61 (1982), 310-316.
36. Rogers, R. S. III, J. P. Tindall: Geriatric herpes zoster. J. Amer. Geriat. Soc. 19 (1971), 495-504.
37. Rothrock, J. F., P. A. Walicke, M.R. Swenson: Neurogenic bladder from occult herpes zoster. Postgrad. Med. 80 (1986), 211-213.
38. Rudra, T.: Zoster sine herpete. Brit. J. Clin. Pract. 44 (1990), 284.
39. Rusthoven, J. J., P. Ahlgren, T. Elhakim et al.: Varizella zoster infection in adult cancer patients: a population study. Arch. intern. Med. 148 (1988), 1561-1566.
40. Schimpff, S., A. Serpick, B. Stoler et al.: Varicella-Zoster infection in patients with cancer. Ann. intern. Med. 76 (1972), 241-254.
41. Senff, H. L., Engelmann, J. Kunze et al.: Allergic contact dermatitis from idoxuridine. Contact Derm. 23 (1990), 43-45.
42. Solomon, A. R., J. E. Rasmussen, J. S. Weis: A comparison of Tzanck smear and virus isolation in varizella and herpes zoster. Arch. Dermatol. 122 (1986), 282-285.
43. Srugo, J., V. Israele, K. A. E. Witte et al.: Clinical manifestations of varicella zoster virus infections in immunodeficiency virus-infected children. Amer. J. Dis. Child. 147 (1993), 742-745.
44. Stewart, A. L., R. D. Hays, J. E. Ware Jr.: The MUS short-form general health survey. Med. Care 26 (1988), 724-735.
45. Tyring, S., R. A. Barbarash, J. E. Nahlik: Famciclovir for the treatment of acute herpes zoster. Ann. intern. Med. 123 (1995), 89-96.
46. Whitley, R. J., H. Weiss, J. Gnann: Acyclovir with and without Prednisone for the treatment of Herpes Zoster. Ann. intern. Med. 125 (1996), 376-383.
47. Whitley, R.: Therapeutic approaches to varicella-zoster virus infections. J. infect. Dis. 166 (1992, Suppl.), S 51-S 57.
48. Wilkerson, M. G., W. P. Jordan, T. M. Kerkering: Herpes zoster as a sign of AIDS-related complex. Amer. Family Phycn. 36 (1987), 233.
49. Wood, M. J., R. W. Johnson, T. W. McKendrick, J. Taylor, B. K. Mandai, J. A. Crooks: A randomized trial of acyclovir for 7 days or 21 days with and without prednisolon for treatment of acute herpes zoster. New Engl. J. Med. 330 (1994), 896-900.
50. Wutzler, P., H. W. Doerr: Der Herpes zoster - ein Morbus herpes non simplex. Dtsch. med. Wschr. 120 (1995), 1133-1138.